Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
173.17
+8.40 (5.10%)
Jun 11, 2026, 4:00 PM EDT - Market closed
Tenet Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 21,455 | 21,310 | 20,675 | 20,564 | 19,368 | 19,676 | |
Revenue Growth (YoY) | 4.51% | 3.07% | 0.54% | 6.17% | -1.57% | 6.23% |
Cost of Revenue | 12,594 | 12,485 | 12,448 | 12,736 | 12,117 | 12,206 |
Gross Profit | 8,861 | 8,825 | 8,227 | 7,828 | 7,251 | 7,470 |
Depreciation & Amortization Expenses | 886 | 863 | 818 | 870 | 841 | 855 |
Other Operating Expenses | 4,786 | 4,718 | 1,713 | 4,676 | 4,293 | 3,962 |
Total Operating Expenses | 5,672 | 5,581 | 2,531 | 5,546 | 5,134 | 4,817 |
Operating Income | 3,602 | 3,244 | 5,696 | 2,282 | 2,117 | 2,653 |
Interest Income | 259 | 264 | 260 | 228 | 216 | 218 |
Interest Expense | -822 | -821 | -826 | -901 | -890 | -923 |
Other Non-Operating Income (Expense) | 541 | 113 | 118 | 8 | -98 | -60 |
Total Non-Operating Income (Expense) | -22 | -444 | -448 | -665 | -772 | -765 |
Pretax Income | 3,167 | 2,800 | 5,248 | 1,617 | 1,345 | 1,888 |
Provision for Income Taxes | 516 | 433 | 1,184 | 306 | 344 | 411 |
Net Income | 2,651 | 2,367 | 4,064 | 1,311 | 1,001 | 1,477 |
Minority Interest in Earnings | 948 | 960 | 864 | 700 | 590 | 562 |
Earnings From Discontinued Operations | - | - | - | - | - | -2 |
Net Income to Common | 1,703 | 1,407 | 3,200 | 611 | 411 | 914 |
Net Income Growth | 17.04% | -56.03% | 423.73% | 48.66% | -55.03% | 129.07% |
Shares Outstanding (Basic) | 88 | 90 | 97 | 102 | 107 | 107 |
Shares Outstanding (Diluted) | 89 | 91 | 98 | 105 | 111 | 109 |
Shares Change (YoY) | -7.79% | -7.20% | -6.60% | -5.17% | 1.79% | 2.17% |
EPS (Basic) | 19.39 | 15.61 | 33.02 | 6.01 | 3.84 | 8.56 |
EPS (Diluted) | 19.23 | 15.49 | 32.70 | 5.71 | 3.79 | 8.43 |
EPS Growth | 27.18% | -52.63% | 472.68% | 50.66% | -55.04% | 124.80% |
Free Cash Flow | 3,349 | 2,530 | 1,116 | 1,623 | 321 | 910 |
Free Cash Flow Growth | 32.37% | 126.70% | -31.24% | 405.61% | -64.72% | -68.26% |
Free Cash Flow Per Share | 37.64 | 27.85 | 11.40 | 15.49 | 2.90 | 8.38 |
Gross Margin | 41.30% | 41.41% | 39.79% | 38.07% | 37.44% | 37.96% |
Operating Margin | 16.79% | 15.22% | 27.55% | 11.10% | 10.93% | 13.48% |
Profit Margin | 12.36% | 11.11% | 19.66% | 6.38% | 5.17% | 7.51% |
FCF Margin | 15.61% | 11.87% | 5.40% | 7.89% | 1.66% | 4.62% |
EBITDA | 4,488 | 4,107 | 6,514 | 3,152 | 2,958 | 3,508 |
EBITDA Margin | 20.92% | 19.27% | 31.51% | 15.33% | 15.27% | 17.83% |
EBIT | 3,602 | 3,244 | 5,696 | 2,282 | 2,117 | 2,653 |
EBIT Margin | 16.79% | 15.22% | 27.55% | 11.10% | 10.93% | 13.48% |
Effective Tax Rate | 16.29% | 15.46% | 22.56% | 18.92% | 25.58% | 21.77% |